These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28290843)

  • 1. [Influence of the Potassium Channels Activator Nicorandil to the Quality of Life in Patients With Ishemic Heart Disease and Stable Angina Pectoris].
    Sizova ZM; Zakharova VL; Kozlova NV; Kuchkina TS
    Kardiologiia; 2016 Jun; 56(6):26-31. PubMed ID: 28290843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of Anti-Ischemic and Cardioprotective Effects of Nicorandil in Patients With Stable Angina].
    Rezvanova YA; Adamchik AS
    Kardiologiia; 2015; 55(8):21-5. PubMed ID: 26761967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the Impact of Nicorandil on the Quality of Life and Prognosis Indicators in Patients With Stable Angina].
    Ryabikhin R; Mozheiko ME; Krasilnikova Y
    Kardiologiia; 2016 Dec; 56(11):12-17. PubMed ID: 28290814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels.
    Loubani M; Galiñanes M
    J Thorac Cardiovasc Surg; 2002 Oct; 124(4):750-7. PubMed ID: 12324733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
    Simpson D; Wellington K
    Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil.
    Gomma AH; Purcell HJ; Fox KM
    Drugs; 2001; 61(12):1705-10. PubMed ID: 11693460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator Therapy: Nitrates and Nicorandil.
    Tarkin JM; Kaski JC
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):367-378. PubMed ID: 27311574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of chronic stable angina.
    Dixit D; Kimborowicz K
    JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative Assessment of Antianginal Efficacy and Safety of Nicorandil at the Background of Therapy With -Adrenoblockers in Ischemic Heart Disease Patients With Stable Angina].
    Martsevitch SY; Kutishenko NP; Deev On Behalf Of The Kvazar Study AD
    Kardiologiia; 2016 Oct; 56(10):30-34. PubMed ID: 28290892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].
    Sizova ZM; Kozlova NV; Zakharova VL; Shameeva ES
    Kardiologiia; 2015; 55(2):10-5. PubMed ID: 26164982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M; Landzberg BR; Frishman WH
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nicorandil in the treatment of myocardial ischaemia.
    Falase B; Easaw J; Youhana A
    Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study.
    Jiang J; Li Y; Zhou Y; Li X; Li H; Tang B; Dai X; Ma T; Li L; Huo Y
    Int J Cardiol; 2016 Dec; 224():183-187. PubMed ID: 27657471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
    Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
    Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.